Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease (MAIN COMPARE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02791412 |
Recruitment Status :
Completed
First Posted : June 6, 2016
Last Update Posted : June 26, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Coronary Arteries | Procedure: percutaneous coronary intervention or coronary-artery bypass graft |
Study Type : | Observational |
Actual Enrollment : | 2240 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease in Korea : Multicenter, Long-term, Observational Trial |
Actual Study Start Date : | January 13, 2017 |
Actual Primary Completion Date : | May 30, 2018 |
Actual Study Completion Date : | May 30, 2018 |
Group/Cohort | Intervention/treatment |
---|---|
unprotected left main
undergone percutaneous coronary intervention or coronary artery bypass graft
|
Procedure: percutaneous coronary intervention or coronary-artery bypass graft |
- composite event [ Time Frame: 10 years ]all-cause death, myocardiac infarction, revascularization
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Unprotected left main disease
Exclusion Criteria :
- No exclusion criteria
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02791412
Korea, Republic of | |
Asan Medical Center | |
Seoul, Songpa-gu, Korea, Republic of, 138-736 | |
Chungnam National University Hospital | |
Dae-jeon, Korea, Republic of | |
Kyungpook National University Hospital | |
Daegu, Korea, Republic of | |
Chonnam National University Hospital | |
Gwangju, Korea, Republic of | |
Gachon University Gil Hospital | |
Incheon, Korea, Republic of | |
Samsung Medical Center | |
Seoul, Korea, Republic of | |
Seoul National University Hospital | |
Seoul, Korea, Republic of | |
Severance Hospital | |
Seoul, Korea, Republic of | |
The Catholic University of Korea Seoul St. Mary's Hospital | |
Seoul, Korea, Republic of | |
The Catholic University of Korea, Yeouido St. Mary's Hospital | |
Seoul, Korea, Republic of | |
Seoul National University Bundang hospital | |
Sungnam, Korea, Republic of | |
Ajou University Hospital | |
Suwon, Korea, Republic of |
Responsible Party: | Seung-Jung Park, professor of medicine, Asan Medical Center |
ClinicalTrials.gov Identifier: | NCT02791412 |
Other Study ID Numbers: |
AMCCV2016-08 |
First Posted: | June 6, 2016 Key Record Dates |
Last Update Posted: | June 26, 2018 |
Last Verified: | June 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | This is not a publicly funded trial. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
left main unprotected percutaneous coronary intervention coronary-artery bypass graft |
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |